Cargando…

Combined Virtual and Experimental Screening for CK1 Inhibitors Identifies a Modulator of p53 and Reveals Important Aspects of in Silico Screening Performance

A compound collection of pronounced structural diversity was comprehensively screened for inhibitors of the DNA damage-related kinase CK1. The collection was evaluated in vitro. A potent and selective CK1 inhibitor was discovered and its capacity to modulate the endogenous levels of the CK1-regulate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Myrianthopoulos, Vassilios, Lozach, Olivier, Zareifi, Danae, Alexopoulos, Leonidas, Meijer, Laurent, Gorgoulis, Vassilis G., Mikros, Emmanuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666784/ https://www.ncbi.nlm.nih.gov/pubmed/28984824 http://dx.doi.org/10.3390/ijms18102102

Ejemplares similares

Impact of binding site waters on inhibitor design: contemplating a novel inverse binding mode of indirubin derivatives in DYRK kinases
por: Cappel, Daniel, et al.
Publicado: (2014)

Identification of the Substrate Recognition and Transport Pathway in a Eukaryotic Member of the Nucleobase-Ascorbate Transporter (NAT) Family
por: Kosti, Vasiliki, et al.
Publicado: (2012)

Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases
por: Myrianthopoulos, Vassilios, et al.
Publicado: (2012)

Virtual screening of GPCRs: An in silico chemogenomics approach
por: Jacob, Laurent, et al.
Publicado: (2008)

Screening of Heteroaromatic Scaffolds against Cystathionine Beta-Synthase Enables Identification of Substituted Pyrazolo[3,4-c]Pyridines as Potent and Selective Orthosteric Inhibitors
por: Fantel, Anna-Maria, et al.
Publicado: (2020)

Cockayne Syndrome Group B (CSB): The Regulatory Framework Governing the Multifunctional Protein and Its Plausible Role in Cancer
por: Spyropoulou, Zoi, et al.
Publicado: (2021)

Repositioning of Etravirine as a Potential CK1ε Inhibitor by Virtual Screening
por: Córdova-Bahena, Luis, et al.
Publicado: (2021)

Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis
por: Myrianthopoulos, Vassilios, et al.
Publicado: (2016)

Machine Learning for In Silico Virtual Screening and Chemical Genomics: New Strategies
por: Vert, Jean-Philippe, et al.
Publicado: (2008)

Selective cytotoxicity of the herbal substance acteoside against tumor cells and its mechanistic insights
por: Cheimonidi, Christina, et al.
Publicado: (2018)

Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening
por: Li, Chunqiong, et al.
Publicado: (2020)

An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related protein kinase 3
por: Efstathiou, Antonia, et al.
Publicado: (2014)

Virtual screening and in silico design of novel inhibitors of bacterial lectins
por: Alán, Jan, et al.
Publicado: (2012)

In silico virtual screening approaches for anti-viral drug discovery
por: Murgueitio, Manuela S., et al.
Publicado: (2012)

Empirical Scoring Functions for Structure-Based Virtual Screening: Applications, Critical Aspects, and Challenges
por: Guedes, Isabella A., et al.
Publicado: (2018)

The Role of E3, E4 Ubiquitin Ligase (UBE4B) in Human Pathologies
por: Antoniou, Nikolaos, et al.
Publicado: (2019)

A network-based computational and experimental framework for repurposing compounds toward the treatment of non-alcoholic fatty liver disease
por: Zareifi, Danae Stella, et al.
Publicado: (2022)

Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer
por: Druzhyna, Nadiya, et al.
Publicado: (2016)

High performance in silico virtual drug screening on many-core processors
por: McIntosh-Smith, Simon, et al.
Publicado: (2015)

Identification of potential modulators of IFITM3 by in-silico modeling and virtual screening
por: Tiwari, Vikas, et al.
Publicado: (2022)

Screening for Fatal Traumatic Brain Injuries in Cerebrospinal Fluid Using Blood-Validated CK and CK–MB Immunoassays
por: Zwirner, Johann, et al.
Publicado: (2021)

Evaluation of creatine kinase (CK)-MB to total CK ratio as a diagnostic biomarker for primary tumors and metastasis screening
por: Li, Yan, et al.
Publicado: (2023)

Docking, virtual high throughput screening and in silico fragment-based drug design
por: Zoete, Vincent, et al.
Publicado: (2009)

In Silico Rational Design and Virtual Screening of Bioactive Peptides Based on QSAR Modeling
por: Mahmoodi-Reihani, Mehri, et al.
Publicado: (2020)

Α Humanized RANKL Transgenic Mouse Model of Progestin-Induced Mammary Carcinogenesis for Evaluation of Novel Therapeutics
por: Kolokotroni, Anthi, et al.
Publicado: (2023)

Global Screening of CK2 Kinase Substrates by an Integrated Phosphoproteomics Workflow
por: Bian, Yangyang, et al.
Publicado: (2013)

Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR
por: Li, Wei, et al.
Publicado: (2015)

In Silico Modeling of Crimean Congo Hemorrhagic Fever Virus Glycoprotein-N and Screening of Anti Viral Hits by Virtual Screening
por: Halim, Sobia Ahsan, et al.
Publicado: (2020)

The protein kinase CK1: Inhibition, activation, and possible allosteric modulation
por: Sunkari, Yashoda Krishna, et al.
Publicado: (2022)

Discovery of Anti-Hypertensive Oligopeptides from Adlay Based on In Silico Proteolysis and Virtual Screening
por: Qiao, Liansheng, et al.
Publicado: (2016)

Hyperactivation of Nrf2 increases stress tolerance at the cost of aging acceleration due to metabolic deregulation
por: Tsakiri, Eleni N., et al.
Publicado: (2018)

Discovery of Selective Inhibitors Against EBNA1 via High Throughput In Silico Virtual Screening
por: Li, Ning, et al.
Publicado: (2010)

Discovery of Specific Inhibitors for Intestinal E. coli β-Glucuronidase through In Silico Virtual Screening
por: Cheng, Ta-Chun, et al.
Publicado: (2015)

Combination of Virtual Screening Protocol by in Silico toward the Discovery of Novel 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors
por: Fu, Ying, et al.
Publicado: (2018)

Screening, molecular simulation & in silico kinetics of virtually designed covid-19 main protease inhibitors
por: Aleissa, Mohammed S., et al.
Publicado: (2022)

In-Silico Drug Toxicity and Interaction Prediction for Plant Complexes Based on Virtual Screening and Text Mining
por: Zhang, Feng, et al.
Publicado: (2022)

In Silico Targeting of Fascin Protein for Cancer Therapy: Benchmarking, Virtual Screening and Molecular Dynamics Approaches
por: Hassan, Heba H. A., et al.
Publicado: (2023)

scMAGeCK links genotypes with multiple phenotypes in single-cell CRISPR screens
por: Yang, Lin, et al.
Publicado: (2020)

Advances in virtual screening
por: Muegge, Ingo, et al.
Publicado: (2006)

Virtual screening using covalent docking to find activators for G245S mutant p53
por: Omar, Sara Ibrahim, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_joakaltl2ujs6u294gt95qmu55